在COVID-19引起的呼吸道疾病中使用和研究外源表面活性剂的考虑因素
1Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
概括
外源表面活性剂治疗,研究急性呼吸困扰综合征 (ARDS),显示在早期COVID-19呼吸道疾病的潜力. 需要进一步的研究来探索特定患者群体的益处.
科学领域:
- 肺部医学 肺部医学
- 关键的护理关键的护理
- 传染性疾病 传染性疾病
背景情况:
- 外源表面活性剂治疗已被用于急性呼吸困扰综合征 (ARDS) 的研究,死亡益处的成功有限.
- 随着COVID-19的流行,人们开始重新评估用于呼吸道并发症的表面活性剂疗法.
研究的目的:
- 探索外源表面活性剂治疗在COVID-19呼吸系统疾病中的潜在益处.
- 调查是否在疾病初期的患者,不符合完整的ARDS标准,可能对表面活性剂治疗有好反应.
主要方法:
- 对现有临床试验和生物可信性的审查.
- 在特定患者群体中分析潜在的差异性反应.
主要成果:
- 之前在严重ARDS的试验中没有证明死亡率有好处.
- 生物学理由表明,在早期或不那么严重的疾病阶段有潜在的益处.
结论:
- 患有COVID-19呼吸系统疾病的患者,特别是那些处于早期阶段或不符合全部ARDS标准的患者,可能代表了表面活性剂治疗调查的独特人群.
- 未来的临床试验应考虑对患者进行分层,以确定那些可能从外源表面活性剂中受益的人.
更多相关视频
05:46A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
4.7K
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
2.7K
相关概念视频
Breathing
58.9K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
58.9K
Acute Respiratory Failure-V
124
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
246
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
246
